Medical Care
Global Cancer Oncology Testing Market Research Report 2025
- May 05, 25
- ID: 226132
- Pages: 87
- Figures: 84
- Views: 43
The global market for Cancer Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Oncology Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Oncology Testing.
The Cancer Oncology Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Oncology Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Oncology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Oncology Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Oncology Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies, Natera, Bio Rad Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Oncology Testing.
The Cancer Oncology Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Oncology Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Oncology Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Oncology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Oncology Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluorescence In Situ Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Microarray Technology
1.2.5 Serum Proteomics
1.2.6 Nucleic Acid Sequencing
1.3 Market by Application
1.3.1 Global Cancer Oncology Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.3.6 Biopharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Oncology Testing Market Perspective (2020-2031)
2.2 Global Cancer Oncology Testing Growth Trends by Region
2.2.1 Global Cancer Oncology Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Oncology Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Oncology Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Oncology Testing Market Dynamics
2.3.1 Cancer Oncology Testing Industry Trends
2.3.2 Cancer Oncology Testing Market Drivers
2.3.3 Cancer Oncology Testing Market Challenges
2.3.4 Cancer Oncology Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Oncology Testing Players by Revenue
3.1.1 Global Top Cancer Oncology Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Oncology Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Oncology Testing Revenue
3.4 Global Cancer Oncology Testing Market Concentration Ratio
3.4.1 Global Cancer Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Oncology Testing Revenue in 2024
3.5 Global Key Players of Cancer Oncology Testing Head office and Area Served
3.6 Global Key Players of Cancer Oncology Testing, Product and Application
3.7 Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Oncology Testing Breakdown Data by Type
4.1 Global Cancer Oncology Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Oncology Testing Breakdown Data by Application
5.1 Global Cancer Oncology Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Oncology Testing Market Size (2020-2031)
6.2 North America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Oncology Testing Market Size by Country (2020-2025)
6.4 North America Cancer Oncology Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Oncology Testing Market Size (2020-2031)
7.2 Europe Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Oncology Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Oncology Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Oncology Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Oncology Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Oncology Testing Market Size (2020-2031)
9.2 Latin America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Oncology Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Oncology Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Oncology Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Devyser
11.1.1 Devyser Company Details
11.1.2 Devyser Business Overview
11.1.3 Devyser Cancer Oncology Testing Introduction
11.1.4 Devyser Revenue in Cancer Oncology Testing Business (2020-2025)
11.1.5 Devyser Recent Development
11.2 Agendia
11.2.1 Agendia Company Details
11.2.2 Agendia Business Overview
11.2.3 Agendia Cancer Oncology Testing Introduction
11.2.4 Agendia Revenue in Cancer Oncology Testing Business (2020-2025)
11.2.5 Agendia Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Oncology Testing Introduction
11.3.4 Illumina Revenue in Cancer Oncology Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Details
11.4.2 Personal Genome Diagnostics Business Overview
11.4.3 Personal Genome Diagnostics Cancer Oncology Testing Introduction
11.4.4 Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025)
11.4.5 Personal Genome Diagnostics Recent Development
11.5 Veracyte
11.5.1 Veracyte Company Details
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Cancer Oncology Testing Introduction
11.5.4 Veracyte Revenue in Cancer Oncology Testing Business (2020-2025)
11.5.5 Veracyte Recent Development
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Details
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Cancer Oncology Testing Introduction
11.6.4 Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025)
11.6.5 Pacific Biosciences of California Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Cancer Oncology Testing Introduction
11.7.4 Qiagen Revenue in Cancer Oncology Testing Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Oncology Testing Introduction
11.8.4 Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Cancer Oncology Testing Introduction
11.9.4 Natera Revenue in Cancer Oncology Testing Business (2020-2025)
11.9.5 Natera Recent Development
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Details
11.10.2 Bio Rad Laboratories Business Overview
11.10.3 Bio Rad Laboratories Cancer Oncology Testing Introduction
11.10.4 Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025)
11.10.5 Bio Rad Laboratories Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Details
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Cancer Oncology Testing Introduction
11.11.4 Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025)
11.11.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Oncology Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fluorescence In Situ Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Microarray Technology
1.2.5 Serum Proteomics
1.2.6 Nucleic Acid Sequencing
1.3 Market by Application
1.3.1 Global Cancer Oncology Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.3.6 Biopharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Oncology Testing Market Perspective (2020-2031)
2.2 Global Cancer Oncology Testing Growth Trends by Region
2.2.1 Global Cancer Oncology Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Oncology Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Oncology Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Oncology Testing Market Dynamics
2.3.1 Cancer Oncology Testing Industry Trends
2.3.2 Cancer Oncology Testing Market Drivers
2.3.3 Cancer Oncology Testing Market Challenges
2.3.4 Cancer Oncology Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Oncology Testing Players by Revenue
3.1.1 Global Top Cancer Oncology Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Oncology Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Oncology Testing Revenue
3.4 Global Cancer Oncology Testing Market Concentration Ratio
3.4.1 Global Cancer Oncology Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Oncology Testing Revenue in 2024
3.5 Global Key Players of Cancer Oncology Testing Head office and Area Served
3.6 Global Key Players of Cancer Oncology Testing, Product and Application
3.7 Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Oncology Testing Breakdown Data by Type
4.1 Global Cancer Oncology Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Oncology Testing Breakdown Data by Application
5.1 Global Cancer Oncology Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Oncology Testing Market Size (2020-2031)
6.2 North America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Oncology Testing Market Size by Country (2020-2025)
6.4 North America Cancer Oncology Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Oncology Testing Market Size (2020-2031)
7.2 Europe Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Oncology Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Oncology Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Oncology Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Oncology Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Oncology Testing Market Size (2020-2031)
9.2 Latin America Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Oncology Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Oncology Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Oncology Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Oncology Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Devyser
11.1.1 Devyser Company Details
11.1.2 Devyser Business Overview
11.1.3 Devyser Cancer Oncology Testing Introduction
11.1.4 Devyser Revenue in Cancer Oncology Testing Business (2020-2025)
11.1.5 Devyser Recent Development
11.2 Agendia
11.2.1 Agendia Company Details
11.2.2 Agendia Business Overview
11.2.3 Agendia Cancer Oncology Testing Introduction
11.2.4 Agendia Revenue in Cancer Oncology Testing Business (2020-2025)
11.2.5 Agendia Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Oncology Testing Introduction
11.3.4 Illumina Revenue in Cancer Oncology Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Details
11.4.2 Personal Genome Diagnostics Business Overview
11.4.3 Personal Genome Diagnostics Cancer Oncology Testing Introduction
11.4.4 Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025)
11.4.5 Personal Genome Diagnostics Recent Development
11.5 Veracyte
11.5.1 Veracyte Company Details
11.5.2 Veracyte Business Overview
11.5.3 Veracyte Cancer Oncology Testing Introduction
11.5.4 Veracyte Revenue in Cancer Oncology Testing Business (2020-2025)
11.5.5 Veracyte Recent Development
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Details
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Cancer Oncology Testing Introduction
11.6.4 Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025)
11.6.5 Pacific Biosciences of California Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Cancer Oncology Testing Introduction
11.7.4 Qiagen Revenue in Cancer Oncology Testing Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Oncology Testing Introduction
11.8.4 Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Cancer Oncology Testing Introduction
11.9.4 Natera Revenue in Cancer Oncology Testing Business (2020-2025)
11.9.5 Natera Recent Development
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Details
11.10.2 Bio Rad Laboratories Business Overview
11.10.3 Bio Rad Laboratories Cancer Oncology Testing Introduction
11.10.4 Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025)
11.10.5 Bio Rad Laboratories Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Details
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Cancer Oncology Testing Introduction
11.11.4 Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025)
11.11.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fluorescence In Situ Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Microarray Technology
Table 5. Key Players of Serum Proteomics
Table 6. Key Players of Nucleic Acid Sequencing
Table 7. Global Cancer Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Oncology Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cancer Oncology Testing Market Share by Region (2020-2025)
Table 11. Global Cancer Oncology Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cancer Oncology Testing Market Share by Region (2026-2031)
Table 13. Cancer Oncology Testing Market Trends
Table 14. Cancer Oncology Testing Market Drivers
Table 15. Cancer Oncology Testing Market Challenges
Table 16. Cancer Oncology Testing Market Restraints
Table 17. Global Cancer Oncology Testing Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cancer Oncology Testing Market Share by Players (2020-2025)
Table 19. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Table 20. Ranking of Global Top Cancer Oncology Testing Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cancer Oncology Testing Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cancer Oncology Testing, Headquarters and Area Served
Table 23. Global Key Players of Cancer Oncology Testing, Product and Application
Table 24. Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Oncology Testing Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cancer Oncology Testing Revenue Market Share by Type (2020-2025)
Table 28. Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cancer Oncology Testing Revenue Market Share by Type (2026-2031)
Table 30. Global Cancer Oncology Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cancer Oncology Testing Revenue Market Share by Application (2020-2025)
Table 32. Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cancer Oncology Testing Revenue Market Share by Application (2026-2031)
Table 34. North America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cancer Oncology Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 49. Devyser Company Details
Table 50. Devyser Business Overview
Table 51. Devyser Cancer Oncology Testing Product
Table 52. Devyser Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 53. Devyser Recent Development
Table 54. Agendia Company Details
Table 55. Agendia Business Overview
Table 56. Agendia Cancer Oncology Testing Product
Table 57. Agendia Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 58. Agendia Recent Development
Table 59. Illumina Company Details
Table 60. Illumina Business Overview
Table 61. Illumina Cancer Oncology Testing Product
Table 62. Illumina Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 63. Illumina Recent Development
Table 64. Personal Genome Diagnostics Company Details
Table 65. Personal Genome Diagnostics Business Overview
Table 66. Personal Genome Diagnostics Cancer Oncology Testing Product
Table 67. Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 68. Personal Genome Diagnostics Recent Development
Table 69. Veracyte Company Details
Table 70. Veracyte Business Overview
Table 71. Veracyte Cancer Oncology Testing Product
Table 72. Veracyte Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 73. Veracyte Recent Development
Table 74. Pacific Biosciences of California Company Details
Table 75. Pacific Biosciences of California Business Overview
Table 76. Pacific Biosciences of California Cancer Oncology Testing Product
Table 77. Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 78. Pacific Biosciences of California Recent Development
Table 79. Qiagen Company Details
Table 80. Qiagen Business Overview
Table 81. Qiagen Cancer Oncology Testing Product
Table 82. Qiagen Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 83. Qiagen Recent Development
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Cancer Oncology Testing Product
Table 87. Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. Natera Company Details
Table 90. Natera Business Overview
Table 91. Natera Cancer Oncology Testing Product
Table 92. Natera Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 93. Natera Recent Development
Table 94. Bio Rad Laboratories Company Details
Table 95. Bio Rad Laboratories Business Overview
Table 96. Bio Rad Laboratories Cancer Oncology Testing Product
Table 97. Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 98. Bio Rad Laboratories Recent Development
Table 99. Myriad Genetics Company Details
Table 100. Myriad Genetics Business Overview
Table 101. Myriad Genetics Cancer Oncology Testing Product
Table 102. Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 103. Myriad Genetics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Cancer Oncology Testing Picture
Figure 2. Global Cancer Oncology Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Oncology Testing Market Share by Type: 2024 VS 2031
Figure 4. Fluorescence In Situ Hybridization Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Microarray Technology Features
Figure 7. Serum Proteomics Features
Figure 8. Nucleic Acid Sequencing Features
Figure 9. Global Cancer Oncology Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Oncology Testing Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Speciality Clinics Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Diagnostics Laboratories Case Studies
Figure 15. Biopharmaceutical Companies Case Studies
Figure 16. Cancer Oncology Testing Report Years Considered
Figure 17. Global Cancer Oncology Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cancer Oncology Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cancer Oncology Testing Market Share by Region: 2024 VS 2031
Figure 20. Global Cancer Oncology Testing Market Share by Players in 2024
Figure 21. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Oncology Testing Revenue in 2024
Figure 23. North America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 25. United States Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 29. Germany Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Oncology Testing Market Share by Region (2020-2031)
Figure 37. China Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 45. Mexico Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 49. Turkey Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Devyser Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 53. Agendia Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 54. Illumina Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 55. Personal Genome Diagnostics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 56. Veracyte Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 57. Pacific Biosciences of California Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 60. Natera Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 61. Bio Rad Laboratories Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 62. Myriad Genetics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Cancer Oncology Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fluorescence In Situ Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Microarray Technology
Table 5. Key Players of Serum Proteomics
Table 6. Key Players of Nucleic Acid Sequencing
Table 7. Global Cancer Oncology Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cancer Oncology Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cancer Oncology Testing Market Share by Region (2020-2025)
Table 11. Global Cancer Oncology Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cancer Oncology Testing Market Share by Region (2026-2031)
Table 13. Cancer Oncology Testing Market Trends
Table 14. Cancer Oncology Testing Market Drivers
Table 15. Cancer Oncology Testing Market Challenges
Table 16. Cancer Oncology Testing Market Restraints
Table 17. Global Cancer Oncology Testing Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cancer Oncology Testing Market Share by Players (2020-2025)
Table 19. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Table 20. Ranking of Global Top Cancer Oncology Testing Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cancer Oncology Testing Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cancer Oncology Testing, Headquarters and Area Served
Table 23. Global Key Players of Cancer Oncology Testing, Product and Application
Table 24. Global Key Players of Cancer Oncology Testing, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Oncology Testing Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cancer Oncology Testing Revenue Market Share by Type (2020-2025)
Table 28. Global Cancer Oncology Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cancer Oncology Testing Revenue Market Share by Type (2026-2031)
Table 30. Global Cancer Oncology Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cancer Oncology Testing Revenue Market Share by Application (2020-2025)
Table 32. Global Cancer Oncology Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cancer Oncology Testing Revenue Market Share by Application (2026-2031)
Table 34. North America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cancer Oncology Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cancer Oncology Testing Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cancer Oncology Testing Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cancer Oncology Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cancer Oncology Testing Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cancer Oncology Testing Market Size by Country (2026-2031) & (US$ Million)
Table 49. Devyser Company Details
Table 50. Devyser Business Overview
Table 51. Devyser Cancer Oncology Testing Product
Table 52. Devyser Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 53. Devyser Recent Development
Table 54. Agendia Company Details
Table 55. Agendia Business Overview
Table 56. Agendia Cancer Oncology Testing Product
Table 57. Agendia Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 58. Agendia Recent Development
Table 59. Illumina Company Details
Table 60. Illumina Business Overview
Table 61. Illumina Cancer Oncology Testing Product
Table 62. Illumina Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 63. Illumina Recent Development
Table 64. Personal Genome Diagnostics Company Details
Table 65. Personal Genome Diagnostics Business Overview
Table 66. Personal Genome Diagnostics Cancer Oncology Testing Product
Table 67. Personal Genome Diagnostics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 68. Personal Genome Diagnostics Recent Development
Table 69. Veracyte Company Details
Table 70. Veracyte Business Overview
Table 71. Veracyte Cancer Oncology Testing Product
Table 72. Veracyte Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 73. Veracyte Recent Development
Table 74. Pacific Biosciences of California Company Details
Table 75. Pacific Biosciences of California Business Overview
Table 76. Pacific Biosciences of California Cancer Oncology Testing Product
Table 77. Pacific Biosciences of California Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 78. Pacific Biosciences of California Recent Development
Table 79. Qiagen Company Details
Table 80. Qiagen Business Overview
Table 81. Qiagen Cancer Oncology Testing Product
Table 82. Qiagen Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 83. Qiagen Recent Development
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Cancer Oncology Testing Product
Table 87. Agilent Technologies Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 88. Agilent Technologies Recent Development
Table 89. Natera Company Details
Table 90. Natera Business Overview
Table 91. Natera Cancer Oncology Testing Product
Table 92. Natera Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 93. Natera Recent Development
Table 94. Bio Rad Laboratories Company Details
Table 95. Bio Rad Laboratories Business Overview
Table 96. Bio Rad Laboratories Cancer Oncology Testing Product
Table 97. Bio Rad Laboratories Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 98. Bio Rad Laboratories Recent Development
Table 99. Myriad Genetics Company Details
Table 100. Myriad Genetics Business Overview
Table 101. Myriad Genetics Cancer Oncology Testing Product
Table 102. Myriad Genetics Revenue in Cancer Oncology Testing Business (2020-2025) & (US$ Million)
Table 103. Myriad Genetics Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Cancer Oncology Testing Picture
Figure 2. Global Cancer Oncology Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Oncology Testing Market Share by Type: 2024 VS 2031
Figure 4. Fluorescence In Situ Hybridization Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Microarray Technology Features
Figure 7. Serum Proteomics Features
Figure 8. Nucleic Acid Sequencing Features
Figure 9. Global Cancer Oncology Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cancer Oncology Testing Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Speciality Clinics Case Studies
Figure 13. Research Institutes Case Studies
Figure 14. Diagnostics Laboratories Case Studies
Figure 15. Biopharmaceutical Companies Case Studies
Figure 16. Cancer Oncology Testing Report Years Considered
Figure 17. Global Cancer Oncology Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Cancer Oncology Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Cancer Oncology Testing Market Share by Region: 2024 VS 2031
Figure 20. Global Cancer Oncology Testing Market Share by Players in 2024
Figure 21. Global Top Cancer Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Oncology Testing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Oncology Testing Revenue in 2024
Figure 23. North America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 25. United States Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 29. Germany Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Oncology Testing Market Share by Region (2020-2031)
Figure 37. China Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 45. Mexico Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Oncology Testing Market Share by Country (2020-2031)
Figure 49. Turkey Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Cancer Oncology Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Devyser Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 53. Agendia Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 54. Illumina Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 55. Personal Genome Diagnostics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 56. Veracyte Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 57. Pacific Biosciences of California Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 60. Natera Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 61. Bio Rad Laboratories Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 62. Myriad Genetics Revenue Growth Rate in Cancer Oncology Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232